Trulieve Cannabis (TRLV) Stock Price, News & Analysis
Company Description
Trulieve Cannabis (NYSE: TRLV) is classified in the drug manufacturers - specialty & generic industry within the Medicinal Chemicals & Botanical Products sector and carries a market capitalization of $1.6B, ranking #2,489 among all listed U.S. companies by market cap.
For FY2025, Trulieve Cannabis reported revenue of $1.2B with net income of -$116.4M and diluted earnings per share of $-0.58. The company operates at a net profit margin of -9.8%.
This page collects what Stock Titan holds for TRLV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Trulieve Cannabis (TRLV) stock last closed at $8.33. At a market capitalization of $1.6B, TRLV is classified as a small-cap stock with approximately 192.3M shares outstanding.
TRLV Rankings
Latest News
Trulieve Cannabis has 6 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include conferences, earnings date. View all TRLV news →
SEC Filings
Trulieve Cannabis has filed 5 recent SEC filings, including 2 Form 4, 1 Form SCHEDULE 13G, 1 Form 8-K, 1 Form DEF 14A. The most recent filing was submitted on July 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRLV SEC filings →
Insider Radar
Insider selling at Trulieve Cannabis over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Trulieve Cannabis generated $1.2B in revenue in FY2025, retaining a 60.2% gross margin, operating income reached $143.5M (12.2% operating margin), and net income was -$116.4M, reflecting a -9.8% net profit margin. Diluted earnings per share stood at $-0.58. The company generated $272.8M in operating cash flow. With a current ratio of 4.43, the balance sheet reflects a strong liquidity position.
Upcoming Events
Q2 Earnings Call
CEO terminates ASDP
Trulieve Cannabis has 2 upcoming scheduled events. The next event, "Q2 Earnings Call", is scheduled for August 7, 2026 (in 10 days). Investors can track these dates to stay informed about potential catalysts that may affect the TRLV stock price.
Short Interest History
Short interest in Trulieve Cannabis (TRLV) currently stands at 1.7 million shares, up 115.1% from the previous reporting period, representing 1.1% of the float. Since June 2026, short interest has increased by 489.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Trulieve Cannabis (TRLV) currently stands at 1.7 days, up 66% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 66% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.
TRLV Company Profile & Sector Positioning
Trulieve Cannabis (TRLV) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Medicinal Chemicals & Botanical Products sector and is listed on the NYSE. In monthly performance, the stock ranks #3,165 among all tracked companies.